Trial Profile
A prospective pilot study of immunological and radiological effects of intrathecal rituximab in patients with secondary progressive multiple sclerosis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2016
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 07 Nov 2016 This trial was discontinued in Denmark, according to European Clinical Trials Database.
- 09 May 2013 New trial record